Page 2 - கேம்பிரிட்ஜ் பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share The team has received funding from the National Institute for Health Research to develop a test that could complement existing antibody tests. They also aim to use similar biological signatures to develop a test and monitor for long COVID. While most people recover from COVID-19 in a matter of days or weeks, around one in ten people go on to develop symptoms that can last for several months. This can be the case irrespective of the severity of their COVID-19 – even individuals who were asymptomatic can experience so-called ‘long COVID’. Diagnosing long COVID can be a challenge, however. A patient with asymptomatic or mild disease may not have taken a PCR test at the time of infection – the gold standard for diagnosing COVID-19 –  and so has never had a confirmed diagnosis.  Even antibody tests – which look for immune cells produced in response to infection – are estimated to miss around 30% of cases, particularly among those who have had only mild disease and

United kingdomNyarie sitholeUniversity of cambridgeCambridge university hospitalNational institute for health researchAddenbrooke charitableDepartment of medicineNational instituteHealth researchMark willsஒன்றுபட்டது கிஂக்டம்பல்கலைக்கழகம் ஆஃப் கேம்பிரிட்ஜ்கேம்பிரிட்ஜ் பல்கலைக்கழகம் மருத்துவமனைதேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சிதுறை ஆஃப் மருந்துதேசிய நிறுவனம்